Patents and Patent Applications
Patent | Application Number | Patent Number |
---|---|---|
“Amphiphilic polynucleotides”, 2022. | ,11512314 |
Patent | Application Number | Patent Number |
---|---|---|
“Therapeutic agents comprising a BMP-9 peptide and eleastin-like peptides”, 2021. | ,11103558 | |
“Direct detection of RNA by surface initiated enzymatic polymerization”, 2021. | ,11130987 | |
“Non-fouling polymeric surface modification and signal amplification method for biomolecular detection”, 2021. | ,11130989 | |
“Triblock polypeptide-based nanoparticles for the delivery of hydrophilic drugs”, 2021. | ,11135301 | |
“Unstructured non-repetitive polypeptides having LCST behavior”, 2021. | ,11155584 | |
“Chips, detectors, and methods of making and using the same”, 2021. | ,11169150 | |
“Dual agonist fusion proteins”, 2021. | ,||
“Nanoparticulate drug delivery systems”, U.S. Patent 17/2728872021. | ,17/272887 | |
“Genetically Encoded Polypeptide for Affinity Capture and Purification of Biologics”, U.S. Patent 17/3495582021. | ,17/349558 | 17349558 |
“Tunable nonfouling surface of oligoethylene glycol”, U.S. Patent US20210047520A12021. | ,US20210047520A1 |
Patent | Application Number | Patent Number |
---|---|---|
“Liquidly injectable, self-stabilizing biopolymers for the delivery of radionuclide”, U.S. Patent WO2020102324A32020. | ,WO2020102324A3 | |
“Therapeutic agents comprising elastin-like peptides”, U.S. Patent US20200282022A12020. | ,US20200282022A1 | |
“Programmable liquid, gel and biohybrid compartments and methods of use”, U.S. Patent US20200276553A12020. | ,US20200276553A1 | |
“Devices and methods for imaging microarray chips”, U.S. Patent WO2020223713A12020. | ,WO2020223713A1 | |
“Amphiphilic polynucleotides”, U.S. Patent US20210009999A12020. | ,US20210009999A1 | |
“Surfaces having reduced non-specific binding and antigenicity”, U.S. Patent US20210046188A12020. | ,US20210046188A1 |
Patent | Application Number | Patent Number |
---|---|---|
“Detection and assay devices and methods of making and using the same”, 2019. | ,US10288607B2 | |
“Targeted therapeutic agents comprising multivalent protein-biopolymer fusions”, U.S. Patent US20190345228A12019. | ,US20190345228A1 | US20190345228A1 |
“Compositions and Methods for Treatment of TRAIL-resistant Cancer.”. U.S. Patent Application No. 15/561,799, 2019. | ,